Bladder cancer

L Dyrskjøt, DE Hansel, JA Efstathiou… - Nature Reviews …, 2023 - nature.com
Bladder cancer is a global health issue with sex differences in incidence and prognosis.
Bladder cancer has distinct molecular subtypes with multiple pathogenic pathways …

Recurrence mechanisms of non-muscle-invasive bladder cancer—A clinical perspective

JYC Teoh, AM Kamat, PC Black, P Grivas… - Nature Reviews …, 2022 - nature.com
Non-muscle-invasive bladder cancer (NMIBC) is an early-stage cancer without invasion into
the detrusor muscle layer. Transurethral resection of bladder tumour (TURBT) is a diagnostic …

Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer

M Ferro, B Barone, F Crocetto, G Lucarelli… - … Oncology: Seminars and …, 2022 - Elsevier
Introduction Seventy-five percent of bladder cancers are non-muscle invasive. The treatment
strategy includes the transurethral resection of bladder tumor (TURB) followed by …

Best practices to optimise quality and outcomes of transurethral resection of bladder tumours

H Mostafid, AM Kamat, S Daneshmand, J Palou… - European Urology …, 2021 - Elsevier
Context Transurethral resection of bladder tumour (TURBT) for bladder cancer (BC) is an
underappreciated common urological procedure. TURBT outcomes are highly variable, and …

En-bloc resection of bladder tumour as primary treatment for patients with non-muscle-invasive bladder cancer: routine implementation in a multi-centre setting

JYC Teoh, N Mayor, KM Li, KL Lo, CF Ng… - World journal of …, 2021 - Springer
Purpose To investigate the technical success rate and 30-day complications of en-bloc
resection of bladder tumour (ERBT) upon routine implementation regardless of tumour size …

[HTML][HTML] National implementation of simulator training improves transurethral resection of bladder tumours in patients

SH Bube, PS Kingo, MG Madsen, JL Vásquez… - European Urology Open …, 2022 - Elsevier
Background Transurethral resection of bladder tumours (TURBT) is the initial diagnostic
treatment for patients with bladder cancer. TURBT is not an easy procedure to master and …

Surgical checklist adherence across urology expertise levels impacts transurethral resection of bladder tumour quality indicators

F Del Giudice, D D'Andrea, B Pradere… - BJU …, 2023 - Wiley Online Library
Objectives To address the association of perioperative surgical checklist across variable
surgical expertise with transurethral resection of bladder tumour (TURBT) accuracy and …

[HTML][HTML] Epigenetic Biomarkers as a New Diagnostic Tool in Bladder Cancer—From Early Detection to Prognosis

N Jaszek, A Bogdanowicz, J Siwiec… - Journal of Clinical …, 2024 - mdpi.com
Bladder cancer (BC) currently ranks as the 9th most common cancer worldwide. It is
characterised by very high rates of recurrence and metastasis. Most cases of BC are of …

En bloc resection of bladder tumors: Challenges and unmet needs in 2022

EN Symeonidis, KL Lo, KL Chui, I Vakalopoulos… - Future …, 2022 - Taylor & Francis
Non-muscle invasive bladder cancer accounts for the majority of new bladder cancer
diagnoses, and endoscopic transurethral resection of bladder tumor (TURBT) represents the …

A 10-year renaissance of en bloc resection of bladder tumors (ERBT): Are we approaching the peak or is it back to the trough?

D Enikeev, A Morozov, A Shpikina, H Fajkovic… - World Journal of …, 2023 - Springer
Background The number of studies suggesting that en bloc resection of bladder tumor
(ERBT) is superior to transurethral resection of bladder tumor (TURBT) for non-muscle …